Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
TransThera announces two oral presentations of tinengotinib clinical data at 2023 ESMO and SABCS annual meetings
2023-10-09 21:00
bioSeedin Biopharma Developer Innovation Conference Held to Accelerate Global Pharmaceutical Innovation and Collaboration
2023-10-09 20:00
Kexing Biopharm Holds China-MENA & South Asia Pharmaceutical Cooperation High-end Forum, Aiming at Foreign Emerging Markets
2023-10-09 19:09
AACR OVARIAN CANCER CONFERENCE PRESENTATION
2023-10-09 15:18
Innovent Announces First Patient Dosed in the Phase 3 Clinical Study (STAR) of Efdamrofusp Alfa (IBI302), a First-in-class Ophthalmic Anti-VEGF and Anti-Complement Bispecific Fusion Protein for the Treatment of Neovascular Age-related Macular Degeneration
2023-10-09 08:00
CANbridge Announces Marketing Approval of CAN108 (/LIVMARLI®) in Taiwan for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome (ALGS)
2023-10-09 08:00
Xinhua Silk Road: Xinhua-Hengshan Astragalus Membranaceus Market Index unveiled in China's Shanxi
2023-10-08 10:02
FDA Grants Orphan Drug Designation to GC Biopharma's Drug Candidate for Thrombotic Thrombocytopenic Purpura
2023-10-06 08:12
Everest Medicines' Partner Calliditas Presents New Data from the NefIgArd Phase 3 Trial at the 17th International Symposium on IgA Nephropathy Tokyo 2023
2023-10-05 07:33
Amcor's AmSky™ and AmPrima™ earn Walmart's 'Circular Connector' seal of approval
2023-10-04 23:55
Large-scale proteomics in population-based studies from UK and Iceland
2023-10-04 23:00
Kensing to Acquire AOM
2023-10-04 21:00
FDA Grants Transcenta Clearance to Proceed with Global Phase III Trial of Osemitamab (TST001) as First-Line Treatment for Gastric/Gastroesophageal Cancer Patients
2023-10-04 08:00
FDA Grants Transcenta Clearance to Proceed with Global Phase III Trial of Osemitamab (TST001) as First-Line Treatment for Gastric/Gastroesophageal Cancer Patients
2023-10-04 08:00
Novavax 2023-2024 COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S.
2023-10-04 04:25
First patient treated with Cu-67 SAR-Bombesin in theranostic prostate cancer trial
2023-10-03 20:58
DrinkAid Marks Its Third Anniversary with an Exclusive Partnership with Singapore's Top Artistic Talent -- Tobyato, Jaeyelle, and JONT
2023-10-03 09:00
Caliway's CBL-514 Achieved Better Efficacy than Liposuction, Reducing over 300mL of Subcutaneous Fat on Average in CBL-0202 Study
2023-10-02 21:00
Cambrex Completes $38 Million Capacity Expansion in High Point, North Carolina
2023-10-02 20:51
Flat Medical Secures Series C Funding Led by Taiwania Capital, Poised for Global Market Expansion
2023-10-02 20:30
1
76
77
78
79
80
413